|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | B01D 15/20 | (2006.01) |
| B01D 15/3809 | (2013.01) | ||
| B01D 15/38 | (2006.01) | ||
| C07K 16/065 | (2013.01) | ||
| C07K 16/00 | (2006.01) | ||
| C07K2317/569 | (2013.01) | ||
| C07K 1/22 | (2006.01) | ||
| C07K 1/22 | (2013.01) |
| (11) | Number of the document | 3680000 |
| (13) | Kind of document | T |
| (96) | European patent application number | 19198005.1 |
| Date of filing the European patent application | 2014-03-13 | |
| (97) | Date of publication of the European application | 2020-07-15 |
| (45) | Date of publication and mention of the grant of the patent | 2024-03-13 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 201361787309 P | 2013-03-15 | US |
| (72) |
GOKLEN, Kent E. , US
SUDA, Eric J. , US
UBIERA, Antonio Raul , US
|
| (73) |
GlaxoSmithKline Intellectual Property Development
Limited ,
GSK Medicines Research Centre
Gunnels Wood Road, Stevenage SG1 2NY,
GB
|
| (54) | METHODS FOR PURIFYING ANTIBODIES |
| METHODS FOR PURIFYING ANTIBODIES |